G-CSF treatment in decompensated liver disease: a double-edged sword?

Hepatol Int. 2022 Oct;16(5):979-982. doi: 10.1007/s12072-022-10379-8. Epub 2022 Sep 2.
No abstract available

Publication types

  • Editorial
  • Comment

MeSH terms

  • Granulocyte Colony-Stimulating Factor* / therapeutic use
  • Humans
  • Liver Diseases* / drug therapy

Substances

  • Granulocyte Colony-Stimulating Factor